Liberty Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Liberty Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,400	Closed	-$88K	–	116
2017 Q4	$88K	Hold	1,400	–	–	0.05%	146
2017 Q3	$90K	Hold	1,400	–	–	0.05%	153
2017 Q2	$77K	Hold	1,400	–	–	0.05%	151
2017 Q1	$76K	Sell	1,400 -2,000	-59%	-$110K	0.05%	143
2016 Q4	$191K	Sell	3,400 -2,600	-43%	-$142K	0.12%	108
2016 Q3	$331K	Hold	6,000	–	–	0.22%	90
2016 Q2	$441K	Sell	6,000 -1,775	-23%	-$125K	0.3%	79
2016 Q1	$497K	Sell	7,775 -1,205	-13%	-$76K	0.37%	65
2015 Q4	$618K	Sell	8,980 -775	-8%	-$51.2K	0.47%	63
2015 Q3	$577K	Buy	9,755 +1,905	+24%	+$121K	0.45%	64
2015 Q2	$522K	Buy	7,850 +3,700	+89%	+$244K	0.35%	74
2015 Q1	$268K	Buy	4,150 +550	+15%	+$34.4K	0.18%	92
2014 Q4	$213K	Buy	+3,600	New	+$203K	0.15%	97

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Liberty Capital Management's BMY Position: Q1 2018 in Review

Liberty Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 1,400 shares — an estimated $88K sold.

Liberty Capital Management first reported a position in BMY in Q4 2014 and held it in 13 quarters. The position peaked at $618K in Q4 2015. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

Liberty Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
Liberty Capital Management sold 1,400 Bristol-Myers Squibb shares in Q1 2018, an estimated $88K.
Liberty Capital Management first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 13 quarters.
Liberty Capital Management's Bristol-Myers Squibb position peaked at $618K in Q4 2015.
1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Liberty Capital Management's 13F filing for Q1 2018, filed 25 Apr 2018.